We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock

Delisted

SRRA was delisted on the 30th of June, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
FM
1
Frazier Management
Washington
$12.6M
O
2
OrbiMed
New York
$5.74M
PA
3
Perceptive Advisors
New York
$5.67M
DM
4
Deerfield Management
New York
$4.34M -$1.02M -17,393 -20%
NLVP
5
New Leaf Venture Partners
New York
$4.34M +$79.4K +1,354 +2%
VC
6
Vivo Capital
California
$3.78M
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$2.33M +$2.2M +37,500 New
Millennium Management
8
Millennium Management
New York
$1.48M +$1.34M +22,785 +2,245%
IHM
9
Iguana Healthcare Management
New York
$930K +$880K +15,000 New
SM
10
Sabby Management
Florida
$827K -$1.66M -28,223 -68%
Renaissance Technologies
11
Renaissance Technologies
New York
$503K +$311K +5,297 +188%
GT
12
Greenleaf Trust
Michigan
$328K -$14.7K -250 -5%
SAM
13
Sectoral Asset Management
Quebec, Canada
$313K
SIM
14
Spark Investment Management
New York
$292K +$277K +4,718 New
PAM
15
Panagora Asset Management
Massachusetts
$267K -$61.4K -1,046 -20%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$265K
BCM
17
Bridgeway Capital Management
Texas
$255K +$44K +750 +22%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$85K -$669K -11,407 -89%
William Blair & Company
19
William Blair & Company
Illinois
$71K
DCM
20
DAFNA Capital Management
California
$68K -$324K -5,525 -83%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$66K -$12.6K -215 -17%
ASN
22
Advisory Services Network
Georgia
$58K
Geode Capital Management
23
Geode Capital Management
Massachusetts
$54K
JP Morgan Chase
24
JP Morgan Chase
New York
$51K +$47.7K +813 +13,550%
MA
25
Minerva Advisors
Pennsylvania
$49K